CLARIPEN GRANULES FOR ORAL SUSPENSION 250 mg/5 ml

Approval Date: Jul 26, 2002
Approval ID: 3ddf50801ccf406b
Company: ELPEN PHARMACEUTICAL CO INCSun Pharmaceutical Industries Limited (DP Intermediate)
Type: Therapeutic

Approval Id: 3ddf50801ccf406b
Drug Name: CLARIPEN GRANULES FOR ORAL SUSPENSION 250 mg/5 ml
Product Name: CLARIPEN GRANULES FOR ORAL SUSPENSION 250 mg/5 ml
Approval Number: SIN12033P
Approval Date: 2002-07-26
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: GRANULE, FOR SUSPENSION
Route Of Administration: ORAL
Atc Code: J01FA09
Atc Item Name: clarithromycin
Pharma Manufacturer Name: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path: /organization/teva-pharmaceutical-investments-singapore-pte-ltd

CLARITHROMYCIN

250 mg/5 ml

CLARITHROMYCIN

250 MG/5 ML

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Jul 26, 2002

Approval ID

3ddf50801ccf406b

Type

Therapeutic